Close Menu

NEW YORK – Pacific Biosciences reported after the close of the market on Wednesday that its first quarter 2020 revenues declined 5 percent year over year, attributable to lower instrument revenues.

For the three months ended March 31, the Menlo Park, California-based company recognized total revenues of $15.6 million compared to $16.4 million in Q1 2019, missing analysts' average estimate of $20.1 million. Revenues included $12.3 million in product revenue and $3.3 million in service and other revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.